Sun Pharma to sell cholesterol control drug worldwide under license...
Mumbai, September 28: Pharma major Sun Pharmaceuticals has entered into an exclusive lincensing agreement with US based LIB Therapeutics to develop and commercialise lerodalcibep, a third-generation PCSK9 inhibitor designed to...
